Added to the reduction of liver fibrosis, supplementation with ASD also improved the hepatic function in the CCl4 induced liver injury models, as can be inferred by repression of ALT and AST levels which were hitherto elevated by CCl4 induction (Figure 2). The gene discussed is GPT; the disease is Hepatic fibrosis.